Wasman Jane

CIK 00013524554 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001352455

Recent Transactions

50 trades

Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2026-01-07+50,000→ 92,900 total
Purchase
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2025-05-30$1.69/sh+20,000→ 30,400 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2025-05-23+3,000→ 3,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2025-05-23+2,500→ 12,500 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2025-01-10+12,500→ 22,900 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2025-01-10+18,500→ 18,500 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2024-05-25+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2024-05-25+25,000→ 100,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2024-01-22+10,000→ 10,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2024-01-22+6,000→ 10,400 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2023-05-26+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2023-05-26+25,000→ 75,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2023-02-02+2,500→ 4,400 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2023-02-02+9,500→ 9,500 total
Award
ATHERSYS, INC / NEW
Common Stock
2023-01-09+22,321→ 35,141 total
Award
ATHERSYS, INC / NEW
Stock Option (right to purchase)
2022-09-16+32,042→ 64,084 total
Award
ATHERSYS, INC / NEW
Common Stock
2022-09-16+12,820→ 12,820 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2022-05-20+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2022-05-20+25,000→ 50,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2022-01-31+7,125→ 7,125 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Common Stock
2022-01-31+1,900→ 1,900 total
Award
ATHERSYS, INC / NEW
NonQualified Stock Option (right to purchase)
2021-06-15+50,000→ 50,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2021-05-19+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2021-05-19+25,000→ 25,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2021-03-04+7,500→ 7,500 total
Award
ATHERSYS, INC / NEW
NonQualified Stock Option (right to purchase)
2020-11-12+100,000→ 100,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2020-05-15+55,000→ 55,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2020-03-12+6,500→ 6,500 total
Sale
Acorda Therapeutics, Inc.
Common Stock
2019-12-02$1.60/sh−2,227→ 117,420 total
Award
Acorda Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-11-07+80,000→ 80,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2019-05-23+13,750→ 13,750 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option ( Right to Buy)
2019-04-01+80,000→ 80,000 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2019-03-14+25,000→ 25,000 total
Award
Acorda Therapeutics, Inc.
Common Stock
2019-03-08+12,813→ 119,647 total
Award
Acorda Therapeutics, Inc.
Employee Stock Option (right to buy)
2019-03-08+21,355→ 21,355 total
Tax Payment
Acorda Therapeutics, Inc.
Common Stock
2019-02-21$13.38/sh−953→ 106,834 total
Award
Acorda Therapeutics, Inc.
Common Stock
2018-12-22+2,500→ 107,787 total
Sale
Acorda Therapeutics, Inc.
Common Stock
2018-12-03$20.52/sh−3,067→ 105,287 total
Tax Payment
Acorda Therapeutics, Inc.
Common Stock
2018-11-05$20.28/sh−955→ 108,354 total
Award
Acorda Therapeutics, Inc.
Common Stock
2018-09-10+2,500→ 109,309 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2018-06-12+5,500→ 5,500 total
Award
SELLAS Life Sciences Group, Inc.$SLS
Stock Option (Right to Buy)
2018-03-13+11,000→ 11,000 total
Tax Payment
Acorda Therapeutics, Inc.
Common Stock
2018-03-08$25.65/sh−2,470→ 106,809 total
Exercise/Conversion
Acorda Therapeutics, Inc.
Employee Stock Option (right to buy)
2018-03-05−2,980→ 0 total
Exercise/Conversion
Acorda Therapeutics, Inc.
Common Stock
2018-03-05$19.81/sh+2,980→ 111,553 total
Tax Payment
Acorda Therapeutics, Inc.
Common Stock
2018-03-05$25.95/sh−2,274→ 109,279 total
Award
Acorda Therapeutics, Inc.
Common Stock
2018-02-22+6,463→ 108,573 total
Exercise/Conversion
Acorda Therapeutics, Inc.
Common Stock
2018-01-19$19.81/sh+34,520→ 136,630 total
Sale
Acorda Therapeutics, Inc.
Common Stock
2018-01-19$28.63/sh−350→ 102,110 total
Sale
Acorda Therapeutics, Inc.
Common Stock
2018-01-19$27.58/sh−34,170→ 102,460 total

Companies

Recent Filings

Address

C/O SELLAS LIFE SCIENCES GROUP, INC., 7 TIMES SQUARE, SUITE 2503

NEW YORK, NY, 10036

View on SEC.gov